2024-02-08 21:59:05 ET
Sensus Healthcare, Inc. (SRTS)
Q4 2023 Earnings Conference Call
February 08, 2024, 04:30 PM ET
Company Participants
Kim Golodetz - LHA, IR
Joe Sardano - Chairman and CEO
Michael Sardano - President and General Counsel
Javier Rampolla - CFO
Conference Call Participants
Alex Nowak - Craig-Hallum Capital
Yi Chen - H.C. Wainwright
Anthony Vendetti - Maxim Group
Ben Haynor - Alliance Global Partners
Presentation
Operator
Good day and welcome to the Sensus Healthcare Fourth Quarter and Full Year 2023 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please also note that this event is being recorded today.
I would now like to turn the conference over to Kim Golodetz. Please go ahead.
Kim Golodetz
Thank you, operator. This is Kim Golodetz with LHA. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel; and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address activities Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future are forward-looking statements.
The forward-looking statements are management's beliefs based on currently available information as of the date of this conference call, February 8, 2024. Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements except as required by law. All forward-looking statements are subject to risks and uncertainties, as described in the company's Forms 10-K and 10-Q.
During today's call, references will be made to certain non-GAAP financial measures. Sensus believes these measures provide useful information for investors, yet they should not be considered as a substitute for GAAP, nor should they be viewed, as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today's financial results press release....
Read the full article on Seeking Alpha
For further details see:
Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript